Unlocking the Secrets of NextGen Sequencing in Healthcare

22 Feb 2025 · 2 min
1:57

Robert Whitfield MD switched his program to NGS for all explant testing in 2019, claiming the largest experience. NGS doesn't show antibiotic sensitivity, so cultures run alongside it. Whitfield stopped offering microsurgery to patients with MTHFR mutations around 2017-2018 after noting the ~40% prevalence and hypercoagulability link.

Questions this video answers

2019

No — NGS does not provide antibiotic sensitivity; a traditional culture may be sent as well to obtain sensitivities.

About 40% of the population

Around 2017–2018 (speaker said "I stopped doing that in 2000, maybe 17, 18").

Chapters

More from Robert

0:46
youtube.com

IT'S NOT MOLD

17h ago
40:02
youtube.com

Do You Need a Lift After Explant? Surgeon Explains Scars & Healing

17h ago
0:37
youtube.com

Donor-Derived Adipose Matrix and Breast Lumps

18h ago
0:44
youtube.com

Live Tonight: After Explant Lift, Fat Transfer, or Both?

18h ago
1:14
youtube.com

Why Breast Lift Planning Goes Beyond Photos

1d ago
0:48
youtube.com

Fat Transfer Donor Areas: BodyTite and Morpheus8

1d ago
0:31
youtube.com

Will They Sag After Explant? Three Factors That Matter

2d ago
0:48
youtube.com

Breast Lift vs. Fat Transfer After Explant

2d ago
0:53
youtube.com

Can Shape Be Restored Without Another Implant?

3d ago
0:45
youtube.com

Combined or Staged After Explant?

3d ago
1:12
youtube.com

How Breast Fat Transfer Is Planned

4d ago
See all content